172 related articles for article (PubMed ID: 16697896)
21. Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis.
Yoo JS; Zheng CJ; Lee S; Kwak JH; Kim WG
Bioorg Med Chem Lett; 2006 Sep; 16(18):4889-92. PubMed ID: 16809037
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationship analysis of the peptide deformylase inhibitor 5-bromo-1H-indole-3-acetohydroxamic acid.
Petit S; Duroc Y; Larue V; Giglione C; Léon C; Soulama C; Denis A; Dardel F; Meinnel T; Artaud I
ChemMedChem; 2009 Feb; 4(2):261-75. PubMed ID: 19053131
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
Shi W; Duan Y; Qian Y; Li M; Yang L; Hu W
Bioorg Med Chem Lett; 2010 Jun; 20(12):3592-5. PubMed ID: 20510610
[TBL] [Abstract][Full Text] [Related]
24. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
Jain R; Chen D; White RJ; Patel DV; Yuan Z
Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
[TBL] [Abstract][Full Text] [Related]
25. Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
Boularot A; Giglione C; Petit S; Duroc Y; Alves de Sousa R; Larue V; Cresteil T; Dardel F; Artaud I; Meinnel T
J Med Chem; 2007 Jan; 50(1):10-20. PubMed ID: 17201406
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro antibacterial activity of (2S)-N-(substitutedphenyl)-1-[(2R)-2-[(formylhydroxyamino)methyl]-1-oxohexyl]-2-pyrrolidinecarboxamides as potential peptide deformylase inhibitors.
Wang Z; Zhou W
Chem Biol Drug Des; 2009 Jan; 73(1):142-6. PubMed ID: 19152643
[TBL] [Abstract][Full Text] [Related]
27. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
Sharma A; Khuller GK; Sharma S
Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and structure-activity relationship studies of new phenolic DNA gyrase inhibitors.
Lübbers T; Angehrn P; Gmünder H; Herzig S
Bioorg Med Chem Lett; 2007 Aug; 17(16):4708-14. PubMed ID: 17632001
[TBL] [Abstract][Full Text] [Related]
29. Development of screening assays and discovery of initial inhibitors of pneumococcal peptidoglycan deacetylase PgdA.
Bui NK; Turk S; Buckenmaier S; Stevenson-Jones F; Zeuch B; Gobec S; Vollmer W
Biochem Pharmacol; 2011 Jul; 82(1):43-52. PubMed ID: 21501597
[TBL] [Abstract][Full Text] [Related]
30. Peptidomimetic inhibitors of bacterial peptide deformylase.
East SP; Ayscough A; Toogood-Johnson I; Taylor S; Thomas W
Bioorg Med Chem Lett; 2011 Jul; 21(13):4032-5. PubMed ID: 21621999
[TBL] [Abstract][Full Text] [Related]
31. Discovery of piperazic acid peptide deformylase inhibitors with in vivo activity for respiratory tract and skin infections.
Spletstoser JT; Dreabit J; Knox AN; Benowitz A; Campobasso N; Ward P; Cui G; Lewandowski T; McCloskey L; Aubart KM
Bioorg Med Chem Lett; 2019 Aug; 29(16):2410-2414. PubMed ID: 31160176
[TBL] [Abstract][Full Text] [Related]
32. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents.
Zhang J; Zhang L; Li X; Xu W
Curr Med Chem; 2012; 19(13):2038-50. PubMed ID: 22414079
[TBL] [Abstract][Full Text] [Related]
33. Toward More Selective Antibiotic Inhibitors: A Structural View of the Complexed Binding Pocket of
Kirschner H; Heister N; Zouatom M; Zhou T; Hofmann E; Scherkenbeck J; Stoll R
J Med Chem; 2024 Apr; 67(8):6384-6396. PubMed ID: 38574272
[TBL] [Abstract][Full Text] [Related]
34. Targeting metalloenzymes: a strategy that works.
White RJ; Margolis PS; Trias J; Yuan Z
Curr Opin Pharmacol; 2003 Oct; 3(5):502-7. PubMed ID: 14559095
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of peptide deformylase from Staphylococcus aureus in complex with actinonin, a naturally occurring antibacterial agent.
Yoon HJ; Kim HL; Lee SK; Kim HW; Kim HW; Lee JY; Mikami B; Suh SW
Proteins; 2004 Nov; 57(3):639-42. PubMed ID: 15382235
[No Abstract] [Full Text] [Related]
36. Design and synthesis of macrocyclic peptidyl hydroxamates as peptide deformylase inhibitors.
Shen G; Zhu J; Simpson AM; Pei D
Bioorg Med Chem Lett; 2008 May; 18(10):3060-3. PubMed ID: 18093832
[TBL] [Abstract][Full Text] [Related]
37. Biphenyl tetrazole-thiazolidinediones as novel bacterial peptide deformylase inhibitors: Synthesis, biological evaluations and molecular docking study.
Khan FAK; Jadhav KS; Patil RH; Shinde DB; Arote RB; Sangshetti JN
Biomed Pharmacother; 2016 Oct; 83():1146-1153. PubMed ID: 27551762
[TBL] [Abstract][Full Text] [Related]
38. New peptide deformylase inhibitors and cooperative interaction: a combination to improve antibacterial activity.
Goemaere E; Melet A; Larue V; Lieutaud A; Alves de Sousa R; Chevalier J; Yimga-Djapa L; Giglione C; Huguet F; Alimi M; Meinnel T; Dardel F; Artaud I; Pagès JM
J Antimicrob Chemother; 2012 Jun; 67(6):1392-400. PubMed ID: 22378679
[TBL] [Abstract][Full Text] [Related]
39. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.
Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963
[TBL] [Abstract][Full Text] [Related]
40. An improved crystal form of Plasmodium falciparum peptide deformylase.
Robien MA; Nguyen KT; Kumar A; Hirsh I; Turley S; Pei D; Hol WG
Protein Sci; 2004 Apr; 13(4):1155-63. PubMed ID: 15010544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
